XML 40 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

SIGNIFICANT ACCOUNTING POLICIES (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | ---
Oct. 31, 2015 | Mar. 31, 2025 USD ($) agreement $ / shares shares | Mar. 31, 2024 shares | Mar. 17, 2025 USD ($) | Jan. 31, 2025 $ / shares shares | Dec. 31, 2024 $ / shares | Sep. 30, 2024
SIGNIFICANT ACCOUNTING POLICIES |  |  |  |  |  |  |
Number of global licensing and supply agreements | agreement |  | 2 |  |  |  |  |
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares |  | $ 0.001 |  |  |  | $ 0.001 |
Outstanding Stock Options And Warrants |  |  |  |  |  |  |
SIGNIFICANT ACCOUNTING POLICIES |  |  |  |  |  |  |
Antidilutive securities excluded from computation of earnings (loss) per share, amount | shares |  | 18,216,366 | 31,839,345 |  |  |  |
Sales Agreement |  |  |  |  |  |  |
SIGNIFICANT ACCOUNTING POLICIES |  |  |  |  |  |  |
Shares remain for sale | shares |  |  |  |  | 0 |  |
Increase in aggregate gross sales price | $ |  |  |  | $ 20.0 |  |  |
Shares remain available, total gross proceeds | $ |  | $ 19.7 |  |  |  |  |
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares |  |  |  |  | $ 0.001 |  |
2024 Notes |  |  |  |  |  |  |
SIGNIFICANT ACCOUNTING POLICIES |  |  |  |  |  |  |
Interest rate (as a percent) |  |  |  |  |  |  | 7.50%
Amended Pfizer Agreement | Protalix Bio Therapeutics Incorporation | Brazil |  |  |  |  |  |  |
SIGNIFICANT ACCOUNTING POLICIES |  |  |  |  |  |  |
Collaborative arrangement revenues and expenses sharing percentage | 100.00% |  |  |  |  |  |

X
- Definition Collaborative arrangement revenues and expense sharing percentage. + References No definition available. + Details
Name: | plx_CollaborativeArrangementRevenuesExpensesSharingPercentage
Namespace Prefix: | plx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in gross sales price of shares available for future issuance. + References No definition available. + Details
Name: | plx_CommonStockIncreaseInGrossSalesPriceOfSharesReservedForFutureIssuance
Namespace Prefix: | plx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Aggregate value of common shares reserved for future issuance. + References No definition available. + Details
Name: | plx_CommonStockValueOfCapitalSharesReservedForFutureIssuance
Namespace Prefix: | plx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the number of global licensing and supply agreements. + References No definition available. + Details
Name: | plx_NumberOfGlobalLicensingAndSupplyAgreements
Namespace Prefix: | plx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | plx_SignificantAccountingPoliciesLineItems
Namespace Prefix: | plx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=plx_OutstandingStockOptionsAndWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=plx_SalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=plx_SevenPointFivePercentageSeniorSecuredConvertibleNotesDue2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=plx_AmendedPfizerAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=plx_ProtalixBioTherapeuticsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_BR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |